Animal testing associated with

Methodology of Behavioral Testing Associated with Development in Animal Foods... 

In recent years increasing attention has been paid to the possibility of delaying or even reversing the memory loss that accompanies old age or the more tragic loss of human capabilities associated with premature senility - Alzheimer s disease. Progress is hampered by the difficulty of identifying suitable animal tests, and there is presently no reliable therapy. 

The radiation hazard associated with fallout from nuclear weapons testing arises from radioactive isotopes such as these. One of the most dangerous is strontium-90. In the form of strontium carbonate, SrC03, it is incorporated into the bones of animals and human beings, where it remains far a lifetime. 

The way that the aldehyde requirement was discovered by Cormier and Strehler is extraordinary and noteworthy. First, they found that a boiled bacterial extract stimulated luminescence when it was added to a weakly luminescing NADH-activated bacterial extract. They thought that the stimulation was due to certain substances associated with the cell debris existing in the extract. Thus, they tested the extracts of various animal tissues in the hope of finding a substance that would... 

Apart from these two Vertex compounds, only one other caspase inhibitor, BDN-6556, has been used in clinical trials. This compound belongs to the class of oxamyl dipeptides and was originally developed by Idun Pharmaceuticals (taken over by Pfizer). It is the only pan-caspase inhibitor that has been evaluated in humans. BDN-6556 displays inhibitory activity against all tested human caspases. It is also an irreversible, caspase-specific inhibitor that does not inhibit other major classes of proteases, or other enzymes or receptors. The therapeutic potential of BDN-6556 was first evaluated in several animal models of liver disease because numerous publications suggested that apoptosis contributes substantially to the development of some hepatic diseases, such as alcoholic hepatitis, hepatitis B and C (HBV, HCV), non-alcoholic steato-hepatitis (NASH), and ischemia/reperfusion injury associated with liver transplant. Accordingly, BDN-6556 was tested in a phase I study. The drug was safe and... 

Dermal Effects. There have been no reports of adverse dermal effects associated with exposure to endosulfan in humans. When tested in farmers, endosulfan did not cause contact dermatitis (Schuman and Dobson 1985). Studies in experimental animals have shown that dermal exposure to endosulfan is only slightly to moderately irritating at relatively high doses (Hoechst 1983b, 1985c, 1985d, 1989b Industria Prodotti Chimici 1975). 

The localisation of a particular peptide to a particular brain area and possibly associated with a particular transmitter (e.g. CCK with dopamine in mesolimbic pathways) has often prompted a prediction of function (e.g. CCK may have a role in schizophrenia). Animal studies in which the peptide has been injected into the appropriate brain area or tested on slices taken from the brain area have sometimes been taken to confirm such hypotheses. These approaches have lined up the peptides for a whole range of potential roles, some of which are listed in Table 12.4. Whether these predictions are realities will depend on the availability of chemical agents and their evaluation, not only in animals but also in humans. 

ACh is metabolised extraneuronally by the enzyme acetylcholinesterase, to reform precursor choline and acetate. Blocking its activity with various anticholinesterases has been widely investigated and some improvement in memory noted. Such studies have invariably used reversible inhibition because of the toxicity associated with long-term irreversible inhibition of the enzyme. Physostigmine was the pilot drug. It is known to improve memory in animals and some small effects have been seen in humans (reduces number of mistakes in word-recall tests rather than number of words recalled), but it really needs to be given intravenously and has a very short half-life (30 min). 

To determine the toxicity of parathion to warmblooded animals, tests were made with mice, rats, guinea pigs, rabbits, and dogs. Greatest hazards are associated with insecticidal use, but symptoms of toxicity may be detected well in advance of severe toxic actions. 

---